Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -23.11% is 99% above its 5-year average of -3543.33%, near the high end of its 5-year range (-36991.74%–0.00%).
99.81% above its 12-month average of -12374.09%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2025 (2026-03-31): -125.49%.
OPERATING MARGIN
-23.11%
OPERATING MARGIN AVG TTM
-12374.09%
OPERATING MARGIN AVG 3Y
-5550.08%
OPERATING MARGIN AVG 5Y
-3543.33%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+99.81%
CURRENT VS 3Y AVG
+99.58%
CURRENT VS 5Y AVG
+99.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Paranovus Entertainment Technology Ltd.
Market Cap
$3.28M
Operating Margin
-23.11%
TTM Avg
-12374.09%
3Y Avg
-5550.08%
5Y Avg
-3543.33%
Market Cap
$3.30M
Operating Margin
-2781.69%
TTM Avg
-3688.91%
3Y Avg
-3165.01%
5Y Avg
-3029.85%
Market Cap
$3.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-518.01%
5Y Avg
-1135.32%
Market Cap
$3.14M
Operating Margin
-4350.05%
TTM Avg
-3615.82%
3Y Avg
-8354.24%
5Y Avg
-15697.02%
Market Cap
$3.07M
Operating Margin
0.00%
TTM Avg
-11613.39%
3Y Avg
-11298.29%
5Y Avg
-8806.57%
Market Cap
$3.50M
Operating Margin
-3.14%
TTM Avg
-81.95%
3Y Avg
-224.77%
5Y Avg
-179.82%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Paranovus Entertainment Technology Ltd. (PAVS) | $3.28M | -23.11% | -12374.09% | -5550.08% | -3543.33% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -2781.69% | -3688.91% | -3165.01% | -3029.85% |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | 0.00% | 0.00% | -518.01% | -1135.32% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | -4350.05% | -3615.82% | -8354.24% | -15697.02% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | 0.00% | -11613.39% | -11298.29% | -8806.57% |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.50M | -3.14% | -81.95% | -224.77% | -179.82% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
16.5%
Operating Margin
-23.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -125.49% |
| 2025-09-30 | -5.06% |
| 2025-03-31 | -36991.74% |
| 2024-09-30 | -1689.80% |
| 2024-03-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-03-31 | -38.49% |
| 2022-09-30 | -12.27% |
| 2022-03-31 | -86.95% |
| 2021-09-30 | -22.46% |
| 2021-03-31 | -4.36% |
| 2020-09-30 | 16.86% |
| 2020-03-31 | 16.55% |
| 2019-09-30 | 31.32% |
| 2019-03-31 | 35.26% |
| 2018-09-30 | 33.03% |
| 2018-03-31 | 31.33% |
| 2017-09-30 | 34.70% |
